Twist Bioscience (TWST) Other Non-Current Assets (2018 - 2026)

Twist Bioscience (TWST) has reported Other Non-Current Assets for 9 consecutive years, with $5.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 116.49% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $5.4 million (up 116.49% YoY), while the FY2025 annual figure was $4.9 million, up 212.63% from the prior year.
• Other Non-Current Assets grew to $5.4 million in Q1 2026 per TWST's latest filing, from $4.7 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $6.9 million in Q1 2022 and bottomed at $1.6 million in Q3 2024.
• Historically, Other Non-Current Assets has averaged $4.0 million across 5 years, with a median of $3.9 million in 2022.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 351.11% — and 2024, when it sank 72.4%.
• Twist Bioscience's Other Non-Current Assets stood at $2.9 million in 2022, then declined by 2.57% to $2.8 million in 2023, then gained by 21.0% to $3.4 million in 2024, then jumped by 37.3% to $4.7 million in 2025, then grew by 14.88% to $5.4 million in 2026.
• Business Quant data shows TWST's Other Non-Current Assets at $5.4 million in Q1 2026, $4.7 million in Q4 2025, and $4.9 million in Q3 2025.